tiprankstipranks
Trending News
More News >
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
Advertisement

Mirum Pharmaceuticals (MIRM) Revenue

Compare
704 Followers

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had a revenue of 133.01M in the quarter ending Sep 30, 2025, with 4.09%. This bring the company's revenue in the last twelve months to 471.79M, Decreased 9.93%. In the fiscal year ending Dec 31, 2024, Mirum Pharmaceuticals had annual revenue of 336.89M with 80.76% growth.
Revenue (ttm)
471.79M
Revenue Growth
53.66%
P/S Ratio
10.75
Revenue/Employee
$1,008,647
Employees
334
Market Cap
$3.62B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
336.89M150.51M+180.76%
Dec 31, 2023
186.37M109.31M+241.85%
Dec 31, 2022
77.06M57.92M+402.66%
Dec 31, 2021
19.14M-1,913,800,000.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis